Project Grant DP2AT013279
Award Date
9/17/24
Completion Date
8/31/27
Dollars Obligated
$1.4M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Center for Complementary and Integrative Health
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
This Project Grant award of $510,412.27 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund research to investigate the role of the gut microbiota in alcohol seeking and reward-related decision-making. The research will use mouse models and computational modeling to determine if manipulating the gut microbiota, such as through the use of prebiotics, can mitigate alcohol-induced behavioral impairments. The award period...
This federal Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the Research and Training in Complementary and Integrative Health (CFDA 93.213) program, provides $863,500 to Rutgers, The State University of New Jersey to conduct research on the effect of dysbiotic gut microbiota on the transport of short-chain fatty acids and its relevance to autoimmune disorders. The key objectives are to elucidate the mechanism by which gut microbiome impacts...
This $484,314 Project Grant was awarded by the National Science Foundation (NSF) Division of Integrative Organismal Systems under the Biological Sciences program (CFDA 47.074). The funding will support research at Christopher Newport University to investigate the "microbiota-gut-brain axis" and the impact of intestinal barrier dysfunction on aging and neurodegeneration. Key objectives include gaining insights into the cellular and molecular changes associated with an aging gut, how...
This $1,264,863 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research to evaluate the efficacy and neural mechanisms of combining the medication guanfacine (GXR) and the behavioral intervention Mindfulness Oriented Recovery Enhancement (MORE) as an adjunct to buprenorphine maintenance for individuals with opioid use disorder (OUD). The research will be conducted by Rutgers, The State University...
This $196,350 Project Grant was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to Yale University. The grant will fund a project titled "HIV COMPLEX CAUSAL MODELING: GUT MICROBIOME, DRUG USE, AND IMMUNE RESPONSES" from August 1, 2024 to July 31, 2026. The project aims to elucidate the causal relationship between drug use disorders, HIV acquisition, gut microbiome, and immune responses using Mendelian randomization...
This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the NIH's Drug Use and Addiction Research Programs (CFDA 93.279), will fund a $751,043 research project at the University of Massachusetts Medical School focused on investigating the cellular and molecular mechanisms underlying the complex co-morbidity of opioid use disorder (OUD), major depressive disorder (MDD), and HIV in the human brain. The project will leverage single-cell sequencing technologies and other...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,132,500 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The Medical University of South Carolina (MUSC). The grant, effective September 1, 2024 through June 30, 2029, will support research to unravel the complex interactions between gut microbiota and intestinal mucus. The project aims to investigate the mechanisms by which gut bacteria respond to and stimulate mucus production,...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,338,750 Project Grant to Yale University to conduct research on how gut bacteria can influence host feeding behavior and microbiome assembly using the roundworm Caenorhabditis elegans as a model system. The project aims to develop tools and assays to study the molecular mechanisms by which gut microbes can manipulate host feeding decisions, with the goal of gaining insights that may apply to other host-microbe systems. Key...
This $194,400 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will support research on the effects of adolescent alcohol use on the oral microbiome and brain. The awardee, the Medical University of South Carolina, will recruit 126 adolescents (ages 14-18) with varying levels of alcohol use to collect salivary samples to assess the oral microbiome, with a focus on the Lactobacillus...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $155,140 to Rutgers, The State University of New Jersey to explore the relationships between substance use disorders (SUDs) and other forms of psychopathology. The research aims to use advanced quantitative and genetic methods to model the phenotypic overlap between SUDs and other psychiatric conditions, identify relevant genetic variants, and...